NEDD4 and breast carcinoma: Our results indicate that PIP5Kα‐dependent PIP2 production contributes to the activation of PI3K/Akt signalling and breast cancer cell proliferation, which can be impeded by NEDD4, at least partially, through UPS‐mediated PIP5Kα degradation.